Gene expression microarray analysis in cancer biology, pharmacology, and drug development: Progress and potential

Biochemical Pharmacology

Volumn 62, Issue 10, 2001, Pages 1311-1336

  Clarke, Paul A ^a   Te Poele, Robert ^a   Wooster, Richard ^a,b   Workman, Paul ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Cancer; Drug development; Microarray; Pharmacology

Indexed keywords

17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN; 2 MORPHOLINO 8 PHENYLCHROMONE; ALKYLATING AGENT; ANTHRACYCLINE; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; BRCA2 PROTEIN; COMPLEMENTARY DNA; CYCLOSPORIN A; CYTARABINE; DNA TOPOISOMERASE INHIBITOR; DYCLONINE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; GEFITINIB; GENE PRODUCT; GYRASE INHIBITOR; HALOPERIDOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMATINIB; MESSENGER RNA; MEVINOLIN; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; STAUROSPORINE; TACROLIMUS; TRASTUZUMAB; TUMOR MARKER; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CANCER; CANCER CLASSIFICATION; CANCER GENETICS; CANCER GROWTH; CANCER RESEARCH; CLINICAL TRIAL; DATA ANALYSIS; DRUG ACTIVITY; DRUG EFFECT; DRUG SENSITIVITY; DRUG TARGETING; EXPRESSED SEQUENCE TAG; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; IMAGE ANALYSIS; METHODOLOGY; NONHUMAN; NUCLEIC ACID HYBRIDIZATION; PHARMACOGENOMICS; PREDICTION; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 0035892305     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00785-7     Document Type: Note

References (95)

1. Initial sequencing and analysis of the human genome
2. The sequence of the human genome
3. Gene index analysis of the human genome estimates approximately 120,000 genes
4. Genomics, gene expression and DNA arrays
5. Genomic biology
6. The hallmarks of cancer
7. Towards genomic cancer pharmacology: Innovative drugs for the new millenium
8. Discovering novel chemotherapeutic drugs for the third millenium
9. Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns
10. An information-intensive approach to the molecular pharmacology of cancer
11. A comparison of selected mRNA and protein abundances
12. Correlation between protein and mRNA abundance in yeast
13. Pharmacogenomics - It's not just pharmacogenetics
14. Gene expression profiling in drug discovery
15. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
16. Serial analysis of gene expression
17. Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays
18. Expression profiling using cDNA microarrays
19. DNA arrays for analysis of gene expression
20. A concise guide to cDNA microarray analysis
21. Microarrays: Chances and challenges
22. The chipping forecast
23. Light-directed, spatially addressable parallel chemical synthesis
24. High density synthetic oligonucleotide arrays
25. Gen bank
26. A gene map of the human genome
27. DbEST - Database for expressed sequence tags
28. Assessment of clone identity and sequence fidelity for 1189 IMAGE cDNA clones
29. Molecular interactions on microarrays
30. Functional discovery via a compendium of expression profiles
31. Widespread aneuploidy revealed by DNA microarray expression profiling
32. Genome-wide analysis of DNA copy-number changes using cDNA microarrays
33. Molecular portraits of human breast tumours
34. Systematic variation in gene expression patterns in human cancer cell lines
35. In vivo gene expression profile analysis of human breast cancer progression
36. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays
37. Gene expression profiles of laser-captured adjacent neuronal subtypes
38. Genome-directed primers for selective labeling of bacterial transcripts for DNA microarray analysis
39. Total RNA and array-based expression monitoring
40. Use of a cDNA microarray to analyse gene expression patterns in human cancer
41. Gene expression informatics - It's all in your mine
42. Data management and analysis for gene arrays
43. Data analysis and integration: Of steps and arrows
44. Biomedical discovery with DNA arrays
45. Cluster analysis and display of genome-wide expression patterns
46. Interpreting the patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation
47. Innovative cancer drug targets: Genomics, transcriptomics and clinomics
48. Gene expression patterns and cancer
49. A genome-wide transcriptional analysis of the mitotic cell cycle
50. Systematic determination of genetic network architecture
51. The transcriptional program in the response of human fibroblasts to serum
52. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes
53. Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles
54. Identification of c-Myc responsive genes using rat cDNA microarray
55. EGR1 target genes in prostate carcinoma cells identified by microarray analysis
56. Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes
57. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays
58. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene
59. Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and tissue microarrays
60. Detection of differentially expressed genes in lymphomas using cDNA arrays: Identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas
61. Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using complementary DNA microarray
62. Genomic analysis of metastasis reveals an essential role for RhoC
63. A gene expression database for the molecular pharmacology of cancer
64. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors
65. Drug target validation and identification of secondary drug target effects using DNA microarrays
66. Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone
67. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses
68. Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray
69. Pleiotropic resistance to DNA-interactive drugs is associated with increased expression of genes involved in DNA replication, repair and stress response
70. Comparative microarray analysis of gene expression during apoptosis-induction by growth factor deprivation or protein kinase C inhibition
71. DT-diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90
72. Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosis
73. New drug targets for genomic cancer therapy: Success, limitations, opportunities and future challenges
74. Scoring a bullseye against cancer genome targets
75. Changing times: Developing cancer drugs in genomeland
76. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
77. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
78. A Revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
79. Gene-expression profiles in hereditary breast cancer
80. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer
81. Identification by cDNA microarray of genes involved in ovarian carcinogenesis
82. Molecular classification of cutaneous malignant melanoma by gene expression profiling
83. Preoperative chemotherapy induces apoptosis in early breast cancer
84. When the chips are down
85. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesiser
86. Mining the human genome using microarrays of open reading frames
87. Experimental annotation of the human genome using microarray technology
88. Up-converting phosphor reporters for nucleic acid microarrays
89. New developments in microarray technology
90. A literature network of human genes for high-throughput analysis of gene expression
91. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network
92. Translational control: Bridging the gap between genomics and proteomics
93. Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance
94. Resistance to cytotoxic agents
95. DNA chips and microarrays, part 1